BioCryst Pharmaceuticals, Inc.
Status: Publicly traded
Direct answer
BioCryst Pharmaceuticals, Inc. is publicly traded on NASDAQ under the ticker BCRX.
BioCryst Pharmaceuticals, Inc. is a biotechnology company focused on discovering and developing novel, orally administered, small-molecule therapeutics. The company currently markets two key products: Peramivir injection: An intravenous neuraminidase inhibitor, sold under the brand names RAPIVAB, RAPIACTA, and PERAMIFLU, used for the treatment of acute uncomplicated influenza. ORLADEYO: An oral serine protease...
Can you invest in BioCryst Pharmaceuticals, Inc.?
Yes. BioCryst Pharmaceuticals, Inc. is publicly traded on NASDAQ under the ticker BCRX.
View deeper analysis
View detailed research on MarketSnap, including financials, valuation tools, and analyst context.
Open research for BioCryst Pharmaceuticals, Inc.
Detailed equity research is provided by MarketSnap.